InvestorsHub Logo

trading.jeff

11/30/14 6:13 PM

#26623 RE: Titan V #26622

OncoSec on the other hand is working on increasing the response rate itself instead of identifying nonresponders and turning them away from treatment.


Sounds almost unethical. I believe OncoSec has found its niche.

$ONCS

cameron12x

11/30/14 7:20 PM

#26629 RE: Titan V #26622

ONCS is also working on identifying "biomarkers" which will help identify which patients will respond best.

So, they are working both ends of the desired solution, not just turning non-responders into responders.